{"organizations": [], "uuid": "2ab9e5e73ad1e6b75a02bdd83a65ca2f3ac8fcfc", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "", "site_section": "http://www.cnbc.com/id/10000551/device/rss", "section_title": "California", "url": "https://www.cnbc.com/2018/05/08/the-associated-press-arrowhead-research-fiscal-2q-earnings-snapshot.html", "country": "US", "domain_rank": 767, "title": "Arrowhead Research: Fiscal 2Q Earnings Snapshot", "performance_score": 0, "site": "cnbc.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-09T00:16:00.000+03:00", "replies_count": 0, "uuid": "2ab9e5e73ad1e6b75a02bdd83a65ca2f3ac8fcfc"}, "author": "cnbc.com", "url": "https://www.cnbc.com/2018/05/08/the-associated-press-arrowhead-research-fiscal-2q-earnings-snapshot.html", "ord_in_thread": 0, "title": "Arrowhead Research: Fiscal 2Q Earnings Snapshot", "locations": [], "entities": {"persons": [], "locations": [{"name": "pasadena", "sentiment": "none"}, {"name": "calif.", "sentiment": "none"}, {"name": "pasadena", "sentiment": "none"}], "organizations": [{"name": "arrowhead research", "sentiment": "negative"}, {"name": "arrowhead research corp.", "sentiment": "negative"}, {"name": "ap", "sentiment": "negative"}, {"name": "zacks investment research", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "PASADENA, Calif. (AP) _ Arrowhead Research Corp. (ARWR) on Tuesday reported a loss of $14.9 million in its fiscal second quarter.\nThe Pasadena, California-based company said it had a loss of 18 cents per share.\nThe results matched Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was also for a loss of 18 cents per share.\nThe drug developer posted revenue of $650,125 in the period. Its adjusted revenue was $650,000, missing Street forecasts. Three analysts surveyed by Zacks expected $4 million.\nArrowhead Research shares have more than doubled since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $7.76, more than quadrupling in the last 12 months.\nThis story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on ARWR at https://www.zacks.com/ap/ARWR", "external_links": ["https://www.zacks.com/ap/ARWR", "http://automatedinsights.com/ap"], "published": "2018-05-09T00:16:00.000+03:00", "crawled": "2018-05-09T00:35:20.024+03:00", "highlightTitle": ""}